Episodes

Marilyn Huestis on Designer Drugs

April 21, 2017

In this episode Dennis Velasco speaks with Marilyn Huestis from the University of Maryland School of Medicine about novel psychoactive substances (e.g., modafinil, psilocybin, lysergic acid diethylamide, and 3,4-methylenedioxymethamphetamine) and how they simultaneously offer new pharmacotherapies and pose serious health problems. You can read more in the February issue of CPT focused on Designer Drugs.

Listen and subscribe for free on iTunes and Google Play

ClinPharmPod

Marilyn Huestis on Designer Drugs

00:00 / 13:30

Marlene Haffner on Orphan Drugs

November 28, 2016

This episode features Marlene Haffner, MD, MPH of Haffner Associates, LLC discussing orphan drug regulation in the United States and beyond. Read her article which published in the October 2016 issue here.

Listen and subscribe for free on iTunes and Google Play

ClinPharmPod

Marlene Haffner on Orphan Drugs

00:00 / 19:50

Models of Blood Coagulation with guest Satyaprakash Nayak

November 4, 2016

This episode features Dr. Satyaprakash Nayak discussing application of advanced pharmacometrics and quantitative systems pharmacology in hematology. Read his article from the July 2016 issue here. Also, please find additional CPT:PSP articles related to hematology in the Hematology Virtual Issue, which is available here.

Listen and subscribe for free on iTunes and Google Play

PSPod

Models of Blood Coagulation with guest Satyaprakash Nayak

00:00 / 20:39

Bernard Vrijens on Dose Individualization

June 10, 2016

This episode features Bernard Vrijens of WestRock Healthcare discussing quantifying the influence of adherence and dose individualization. Read his Commentary which published in the April 2016 issue here.

Listen and subscribe for free on iTunes and Google Play

ClinPharmPod

Bernard Vrijens on Dose Individualization

00:00 / 7:21

Good Practices in Model-Informed Drug Discovery and Development with guests Scott Marshall, Sandra Visser, and Amy Cheung

May 9, 2016

In this episode, Drs. Scott Marshall from Pfizer, Sandra Visser from Merck, and Amy Cheung from AstraZeneca discuss “Good Practices in Model-Informed Drug Discovery and Development: Practice, Application, and Documentation”: their White Paper published in the March 2016 issue of PSP. You can get free access the White Paper by clicking here.

Listen and subscribe for free on iTunes and Google Play

PSPod

Good Practices in Model-Informed Drug Discovery and Development with guests Scott Marshall, Sandra Visser, and Amy Cheung

00:00 / 27:30